Mental Health Screening for Refugee Women Remains Understudied in U.S. Care
Refugee and asylum-seeking women in the United States face a layered mental health burden, yet the tools most commonly used to identify distress have not been well studied in this population. A systematic review in PLOS One found that although clinicians and researchers frequently rely on instruments such as the PHQ-9, GAD-7, and PCL-5, evidence on how well these screening tools work in adult refugee women remains thin, uneven, and difficult to compare across settings.
The review focused on four implementation outcomes: adoption, appropriateness, acceptability, and fidelity. Those outcomes matter because a screening tool can be familiar to clinicians and still fail in real-world use if it does not fit the language, culture, workflow, or trust environment of the people being screened. For refugee women, that mismatch can be especially consequential. Trauma exposure, forced displacement, language discordance, and different cultural expressions of distress can all alter how symptoms are described, disclosed, and interpreted at the bedside.
A tool that is easy to administer is not necessarily easy to use well.
A Sparse Evidence Base Beneath Familiar Screening Instruments
Investigators searched ten databases without restricting publication year or language and identified 2,011 studies. After 1,041 duplicates were removed in Covidence and 49 more records were manually deduplicated, 921 studies moved into screening. Only 37 met the review’s inclusion criteria, and just three specifically addressed the population of interest: adult women refugees and asylum seekers in the United States.
That narrow yield is the most striking finding in the review. The field has widely adopted brief symptom scales for depression, anxiety, and post-traumatic stress, but implementation evidence in displaced women remains exceptionally limited. The gap is not merely academic. Screening without evidence of fit can produce false reassurance, missed symptoms, or disclosure barriers that leave trauma untreated and depression invisible.
The review found that the three population-specific studies reported qualitative data on appropriateness and acceptability, with positive outcomes. In other words, when women’s perspectives were actually captured, these tools were generally viewed favorably. But the literature did not provide enough consistent information to establish broader patterns for adoption or fidelity, and reporting across implementation outcomes was inconsistent.
Why the U.S. Setting Changes the Meaning of Screening
The decision to limit the review to the United States was not a simple geographic preference. Screening happens inside a particular legal and health system, and those structures shape who gets assessed, when screening occurs, and whether follow-up care exists after a positive result. Refugee status and asylum status are distinct legal categories under U.S. law, and a substantial number of displaced people in the country hold other forms of protection or immigration status. Access to mental health care therefore varies widely.
That variation matters because screening is only the first step in a care pathway. In a fragmented system without universal coverage, a positive PHQ-9 or PCL-5 score may not lead to timely psychotherapy, psychiatric evaluation, or culturally responsive support. The review’s emphasis on implementation outcomes reflects that reality: a screening tool has to work not just as a questionnaire, but as part of a functioning care process.
Language barriers and culturally different expressions of distress add another layer of complexity. Depression, anxiety, and trauma symptoms may present as bodily pain, sleep disturbance, exhaustion, irritability, or spiritual distress rather than through the symptom vocabulary embedded in standard instruments. In that setting, fidelity is not a trivial methodological term; it determines whether clinicians are actually using the tool as intended and whether patients understand the questions enough to answer meaningfully.
Women Refugees Face Compounded Risk, but the Data Trail Is Thin
Women and girls make up roughly half of the global refugee population, and their mental health needs often reflect both the trauma of displacement and gender-specific experiences before, during, and after migration. The review places this population within a larger burden of common mental health disorders that already carries substantial global impact. Anxiety disorders, depressive disorders, somatic symptom and related disorders, and trauma-related disorders all occur at high frequency in displaced populations, and prior estimates suggest particularly heavy burdens of PTSD, depression, and anxiety among refugees overall.
For refugee women, those risks are compounded by caregiving demands, social isolation, legal uncertainty, and barriers to care after arrival. Screening tools were designed to detect symptoms, but they cannot repair structural obstacles on their own. Without evidence that these instruments are being adopted consistently and delivered in ways that fit women’s circumstances, the screening process risks becoming another administrative step rather than a clinical bridge to care.
The review also makes clear that implementation research has not kept pace with clinical need. Studies of validity in general populations do not automatically translate into evidence of appropriateness or acceptability in refugee women. The difference between psychometric performance and real-world implementation can be wide, especially when the clinical encounter crosses language, culture, and trauma history.
What the Review Adds for Clinicians and Health Systems
The practical takeaway is narrow but important: there is not enough evidence to assume that common mental health screening tools are being implemented in a consistently effective way for adult refugee and asylum-seeking women in the United States. The available population-specific data point toward acceptability and appropriateness when women are asked directly, yet the overall literature remains too limited to guide standardized practice with confidence.
That gap leaves health systems with an obvious research priority. Future studies need to examine how screening tools are introduced, translated, interpreted, and linked to follow-up care in real refugee-serving settings. They also need to report implementation outcomes with greater consistency so that adoption, appropriateness, acceptability, and fidelity can be compared across settings and populations.
The question is not whether refugee women should be screened for depression, anxiety, or trauma. The question is how screening can be made accurate, culturally responsive, and clinically actionable inside a care system that is already difficult to navigate.
Until those implementation questions are answered, mental health screening for refugee and asylum-seeking women in the U.S. will remain under-evidenced precisely where the need is greatest.